Using the Internet to Collect Symptoms and the Ability to Carry Out Daily Activities From Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy
Recruitment status was Active, not recruiting
RATIONALE: A study that evaluates a patient's ability to use a clinic waiting room computer to report his symptoms and his ability to carry out daily activities may help doctors understand a patient's use of a computer to report symptoms.
PURPOSE: This clinical trial is studying how well using the internet to collect symptoms and the ability to carry out daily activities works in patients with metastatic prostate cancer that has not responded to hormone therapy.
Other: internet-based intervention
Procedure: assessment of therapy complications
|Official Title:||Collection of Patient-Reported Symptoms and Performance Status Via the Internet|
- Willingness of approached patients to participate in this study [ Designated as safety issue: No ]
- Proportion of enrolled patients who submit an online questionnaire at any given follow-up visit [ Designated as safety issue: No ]
- Proportion of total attended visits during the study period at which a questionnaire was completed (completers:visits) [ Designated as safety issue: No ]
- Comparison of patient-reported symptoms vs clinician-reported symptoms using symptom severity data collected at baseline [ Designated as safety issue: No ]
- Comparison of the mean severity scores for patient vs clinician reporting at day 43 (when patients report before clinicians; clinicians view those reports) vs at day 22 (patients report symptoms after the clinical encounter) [ Designated as safety issue: No ]
|Study Start Date:||December 2006|
- Assess the feasibility of collecting symptom data directly from patients with hormone-refractory metastatic prostate cancer enrolled in a CALGB chemotherapy trial during clinic visits via waiting-area computers.
- Assess, preliminarily, the level of agreement between patient and clinician symptom severity scoring, and measure whether their scores converge when clinicians are exposed to patient self-reports.
OUTLINE: This is a multicenter, pilot study.
Patients are registered into the Symptom Tracking and Reporting (STAR) database, obtain a password, undergo STAR training, and complete a patient-STAR questionnaire after seeing their clinician (baseline self-report) on day 1 of course 2* of chemotherapy.
Patients are reminded to complete online STAR questionnaire before seeing their clinician on day 1 of courses 3, 4, 5, and 6* of chemotherapy. Clinicians review these patient reports before creating their own assessment. Patients also complete a patient feedback survey on day 1 of course 4* of chemotherapy.
Clinicians complete feedback survey at study completion.
NOTE: *All time points are based on scheduled therapy with clinical trial CALGB-90401, CALGB-30607, CALGB-30704, CALGB-40601, CALGB-40603, CALGB-40502, CALGB-70604, CALGB-80405, or CALGB-40503.
PROJECTED ACCRUAL: A total of 300 patients will be accrued for this study.
Please refer to this study by its ClinicalTrials.gov identifier: NCT00417040
Show 95 Study Locations
|Study Chair:||Ethan Basch, MD||Memorial Sloan Kettering Cancer Center|